GMED

Globus Medical, Inc.NYSEHealthcare

$87.92+0.21%ClosedMarket Cap: $11.89B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-26	Wells Fargo	—	Overweight	—
2026-02-25	Barclays	—	Overweight	—
2026-02-25	Needham	—	Buy	—
2026-01-09	Canaccord Genuity	—	Buy	—
2026-01-08	Piper Sandler	—	Overweight	—
2025-12-17	RBC Capital	—	Outperform	—
2025-12-02	Morgan Stanley	—	Overweight	—
2025-11-18	Truist Securities	—	Buy	—
2025-11-10	Barclays	—	Overweight	—
2025-11-07	Wells Fargo	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$4.96	$3.39B	8
Sun Dec 31	$5.51	$3.62B	2
Mon Dec 31	$6.29	$3.96B	1
Tue Dec 31	$7.00	$4.24B	1